A carregar...
MR1-restricted T cells: the new dawn of cancer immunotherapy
Cancer immunotherapy has recently undergone rapid development into a validated therapy for clinical use. The adoptive transfer of engineered autologous T cells, such as chimeric antigen receptor (CAR) T cells, has been remarkably successful in patients with leukemia and lymphoma with cluster of diff...
Na minha lista:
| Publicado no: | Biosci Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Portland Press Ltd.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670570/ https://ncbi.nlm.nih.gov/pubmed/33185693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20202962 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|